Search results for: 'simulation and training'

The CX industry is in a disruptive state as IT decision-makers and customer contact leaders struggle with prioritizing and procuring budgets and persuading executives to align CX and corporate goals. There is a fear of failure in these uncertain times, making organizations less agile than in previous years. Trust, ease of use, and reliability are t...

30 Jan 2020  |  Asia Pacific  |  Market Research

Japanese Light Vehicle Leasing Market, Forecast to 2023

The Japanese Leasing Industry is Healthy and Expects Promising Growth Prospects Driven by Operational Leasing in Both the Corporate and Private Market Segments

Infographics

×

Fleet renewals were the major driver for new company car registrations as a strained economy caused fluctuations in total registrations over the past few years. The benefits of leasing (unlike owning) has boosted the transition from a loan purchase system to a full service operational leasing system since it has enabled corporates to focus on their...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

Frost & Sullivan surveyed 661 IT decision-makers around the globe to IT/Communications to gain a deeper understanding of the impact of COVID-19 and their plans to exceed CX expectations as the world recovers from the pandemic. COVID-19 accelerated the move towards self-service, allowing many companies to invest in technology that deflects calls...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...